Longitudinal Assessment of the Prevalence of Actinic Keratosis and Extensive Risk Factor Evaluation: An Update from the Rotterdam Study

Christopher D. George, Selin Tokez, Loes Hollestein, Luba M. Pardo, Anne J. Keurentjes, Marlies Wakkee, Tamar Nijsten*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)

Abstract

Population-based studies available to analyze the prevalence, risk factors, and longitudinal outlook of actinic keratoses (AKs) are limited. These features mentioned earlier were assessed using Rotterdam study participants aged ≥40 years who underwent a full-body skin examination by a dermatology-trained physician. ORs with 95% confidence intervals were calculated for the associations between risk factors and the presence of AK. Among 8,239 eligible participants, the prevalence of one or more AKs was 21.1% (95% confidence interval = 20.2–22.0) and was higher in men. Male sex, age, lighter hair and eye color, baldness, genetic risk score, and digital photoaging measures (digitally assessed pigmented spots, telangiectasias, and global facial wrinkling) had a positive association with AK. Cigarette smokers had reduced odds of having AK, with current smokers having the lowest risk. Among patients with two AK assessments, there was no difference in the presence of AK during follow-up between treated and untreated participants. In conclusion, genetic risk score and digital photoaging measures showed associations with increased lesion count. At the individual level, patients were most likely to decrease in AK severity group over time, possibly regardless of whether or not participants were treated.

Original languageEnglish
Pages (from-to)2193-2203.e12
JournalJournal of Investigative Dermatology
Volume143
Issue number11
Early online date9 May 2023
DOIs
Publication statusPublished - Nov 2023

Bibliographical note

Funding Information:
The authors thank the participants and staff of the Rotterdam Study. The Rotterdam Study is funded by the Erasmus Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Health Research and Development; the Research Institute for Diseases in the Elderly; the Ministry of Education, Culture and Science; the Ministry of Health, Welfare and Sports; the European Commission (DGXII); and the Municipality of Rotterdam. We would also like to express gratitude to the SUNY Downstate Alumni Association, National Medical Fellowships, and the American Medical Association Foundation for their scholarship support.

Publisher Copyright:
© 2023 The Authors

Fingerprint

Dive into the research topics of 'Longitudinal Assessment of the Prevalence of Actinic Keratosis and Extensive Risk Factor Evaluation: An Update from the Rotterdam Study'. Together they form a unique fingerprint.

Cite this